Profil
Charlie Qi is currently the Senior Vice President-Global Clinical Development at Transcenta Holding Ltd.
and the Head-Oncology Product Development at Roche Global Product Development Center.
Previously, he worked as the Head-Medical Sciences at Hutchison MediPharma Ltd.
from 2012 to 2017.
Postes actifs de Charlie Qi
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur Technique/Scientifique/R&D | 01/08/2020 |
| Roche Global Product Development Center | Corporate Officer/Principal | 01/08/2017 |
Anciens postes connus de Charlie Qi
| Sociétés | Poste | Fin |
|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/08/2017 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Roche Global Product Development Center |